𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong

✍ Scribed by Henry Lik-Yuen Chan

Book ID
116652024
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
100 KB
Volume
51
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Hepatitis B e antigen–negative chronic h
Hepatitis B e antigen–negative chronic hepatitis b in Hong Kong
✍ Henry L. Y. Chan; Nancy W. Y. Leung; Munira Hussain; May L. Wong; Anna S. F. Lok πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 81 KB πŸ‘ 1 views

Hepatitis B e antigen-negative chronic hepatitis B (eΟͺCHB) has been reported in Asia but its prevalence and clinical significance have not been determined. The aims of this study were to determine the prevalence of eΟͺCHB in Hong Kong and the frequency of precore and core promoter mutations in these

Serum HBeAg quantitation during antivira
Serum HBeAg quantitation during antiviral therapy for chronic hepatitis B
✍ Heijtink, Rudolf A.; Kruining, Johannes; Honkoop, Pieter; Kuhns, Mary C.; Hop, W πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 92 KB πŸ‘ 2 views

Hepatitis Be antigen (HBeAg) seroconversion is considered the principal short-term goal of antiviral therapy in chronic hepatitis B. To test whether the pre-and per-treatment HBeAg quantitation has a higher predictive value than that of hepatitis B virus DNA (HBV-DNA) quantitation for the outcome of